Life Pro Asset Management Becton Dickinson & CO Transaction History

Life Pro Asset Management

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 15, 2022	SELL	$234.74 - $275.42 $314,316 - $368,787	-1,339 Closed	0 $0
Q1 2022 May 06, 2022	BUY	$243.64 - $270.48 $39,226 - $43,547	161 Added 13.67%	1,339 $356,000
Q4 2021 Jan 31, 2022	BUY	$230.08 - $250.94 $15,415 - $16,812	67 Added 6.03%	1,178 $296,000
Q3 2021 Nov 12, 2021	BUY	$232.72 - $256.47 $6,283 - $6,924	27 Added 2.49%	1,111 $273,000
Q2 2021 Aug 10, 2021	SELL	$232.65 - $254.58 $2,093 - $2,291	-9 Reduced 0.82%	1,084 $263,000
Q1 2021 Apr 28, 2021	SELL	$232.09 - $256.88 $21,120 - $23,376	-91 Reduced 7.69%	1,093 $266,000
Q4 2020 Feb 08, 2021	BUY	$221.92 - $245.94 $262,753 - $291,192	1,184 New	1,184 $296,000

1,733

252M

586K

649K

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $68.9B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

Get notified when there are updates to the investment portfolio of Life Pro Asset Management, based on Form 13F filings with the SEC.

Stay updated on Life Pro Asset Management with notifications on news.